Novel aspects of transforming growth factor-beta in diabetic kidney disease

Nephron

Volumn 92, Issue 1, 2002, Pages 7-21

  Tsuchida, Ken Ichi ^a   Cronin, Brian ^a   Sharma, Kumar ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; GLUCOSE; GLUCOSE TRANSPORTER 1; MATRIX METALLOPROTEINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C BETA; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; CALCIUM CELL LEVEL; CARDIOVASCULAR AUTOREGULATION; CYTOSKELETON; DIABETIC NEPHROPATHY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE INTAKE; GLUCOSE TRANSPORT SYSTEM; HUMAN; HYPERGLYCEMIA; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; REVIEW; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; VASCULAR SMOOTH MUSCLE;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0036375448     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064486     Document Type: Review

References (184)

1. The extracellular matrix in diabetic nephropathy
2. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator
3. The pathology of diabetic nephropathy
4. Diabetic nephropathy
5. Glomerular cell number in normal subjects and in type 1 diabetic patients
6. Podocyte loss and progressive glomerular injury in type II diabetes
7. Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule
8. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta
9. Rat mesangial cell hypertrophy in response to transforming growth factor-β1
10. Interaction of transforming growth factor beta 1 with human glomerular epithelial cells in culture: Opposite effects on synthesis of matrix proteins and on urokinase plasminogen activator
11. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β
12. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1
13. TGF-β: Regulation of extracellular matrix
14. Apoptosis in podocytes induced by TGF-beta and Smad7
15. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: Mediation by autocrine activation of TGF-beta
16. Interstitial pathomechanisms underlying progressive tubulointerstitial damage
17. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction
18. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse
19. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy
20. mRNA expression of growth factors in glomeruli from diabetic rats
21. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy
22. Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice
23. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes
24. Long-term prevention of renal insufficieny, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice
25. Renal TGF-beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells
26. Transforming growth factor-beta2 antibody attenuated fibrosis in the experimental diabetic rat kidney
27. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, DPB 9195
28. Expression of transforming growth factor-beta isoforms in human glomerular diseases
29. Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus
30. Increased renal production of transforming growth factor-β 1 in patients with type II diabetes
31. Captopril-induced reduction of serum levels of transforming growth factor-β1 correlates with long-term renoprotection in insulin-dependent diabetic patients
32. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression
33. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats
34. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease
35. Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration
36. Glucose transporters of the glomerulus and the implications for diabetic nephropathy
37. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype
38. Insulin-responsive glucose transporter expression in renal microvessels and glomeruli
39. TGF-beta 1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells
40. Activation of protein kinase C in glomerular cells in diabetes: Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy
41. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats
42. Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation
43. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor
44. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes
45. Translocation of protein kinase C alpha and zeta in rat glomerular mesangial cells cultured under high glucose conditions
46. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells
47. Effect of high glucose on mesangial cell protein kinase C-delta and -epsilon is polyol pathway-dependent
48. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions
49. Extracellular signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells
50. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells
51. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-b1 promoter in mesangial cells
52. Characterization of the mouse transforming growth factor-β1 promoter and activation by the Ha-ras oncogene
53. Transcriptional control of metabolic regulation genes by carbohydrates
54. Definition of the carbohydrate response element of the rat S14 gene: Context of the CACGTG motif determines the specificity of carbohydrate regulation
55. 14 gene expression in hepatocytes
56. Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose
57. USF-1 contributes to glucose-induced TGF-b1 gene activity
58. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation
59. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
60. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-B
61. High glucose levels enhance TGF-beta1-thrombospondin-1 pathway in cultured human mesangial cells via mechanisms dependent on glucose-induced PKC activation
62. Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose
63. Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1
64. The role of thrombospondin in renal disease
65. Angiotensin II-induced hypertrophy of culture murine proximal tubular cells by endogenous TGF-β
66. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells
67. Cyclic stretching forces selectively up-regulates transforming growth factor-b isoforms in cultured rat mesangial cells
68. Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent
69. Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β 1 and phorbol ester occurs through the same target sequences
70. Characterization of the promoter region of the human transforming growth factor-β1 gene
71. Autoinduction of transforming growth factor b1 is mediated by the AP-1 complex
72. Transforming growth factor beta in tissue fibrosis
73. Role of transforming growth factor beta in human disease
74. The emerging role of transforming growth factor-beta in kidney diseases
75. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy
76. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1
77. Role of proteoglycans and cytoskeleton in the effects of TGFβ1 on renal proximal tubule cells
78. TGF-beta: Regulation of extracellular matrix
79. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: Possible role in diabetic nephropathy
80. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta
81. The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells
82. Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase
83. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells
84. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis
85. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney
86. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice
87. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions
88. Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease
89. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice
90. Controlling TGF-beta signaling
91. How cells read TGF-beta signals
92. Positive and negative regulation of TGF-beta signaling
93. Smad proteins and transforming growth factor-beta signaling
94. Mechanism of transforming growth factor-beta1 signaling
95. Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-beta in mesangial cells
96. Transforming growth factor-b1 stimulates protein kinase A in mesangial cells
97. Identification of two Smad4 proteins in Xenopus: Their common and distinct properties
98. Xenopus Smad4beta is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes
99. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein
100. Human Smad3 and Smad4 are sequence-specific transcription activators
101. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
102. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2
103. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription
104. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene
105. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling
106. The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain
107. Smad6 inhibits signalling by the TGF-beta superfamily
108. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling
109. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway
110. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA
111. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-β-induced gene expression
112. Mitogen-activated protein kinase cascades and regulation of gene expression
113. Rho family members: Activators of MAP kinase cascades
114. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway
115. Transforming growth factor beta 2 stimulates acute and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells
116. TGF-beta1 activates MAP kinase in human mesangial cells: A possible role in collagen expression
117. Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: Role of the p38 MAPK pathway
118. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta)
119. CREB is activated by UVC through a p38/HOG-1-dependent protein kinase
120. TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase
121. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3
122. Interdependent SMAD JNK signaling in transforming growth factor-beta-mediated transcription
123. Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta
124. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1
125. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras
126. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells
127. Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: The involvement of protein kinases A and C
128. Regulation of Smad signaling by protein kinase C
129. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: Involvement of Smad3
130. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta
131. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription
132. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators
133. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells
134. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells
135. Overlapping pathways mediate the opposing actions of tumor necrosis factor-alpha and transforming growth factor-beta on alpha 2(I) collagen gene transcription
136. Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor β-related signaling
137. Functional characterization of transforming growth factor B signaling in Smad2 and Smad3-deficient fibroblasts
138. Fibronectin production stimulated by TGF-b is independent of Smad4-pathway in mouse mesangial cells
139. Pirfenidone reduces fibronectin synthesis by cultured human retinal pigment epithelial cells
140. 1 stimulate fibronectin gene expression through a cAMP response element
141. Plasminogen activator inhibitor 1 and atherothrombosis
142. The fat mouse: A powerful genetic model to study hemostatic gene expression in obesity/NIDDM
143. Plasminogne-activator inhibitor type 1 and coronary artery disease
144. Tranforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts
145. Targeted disruption of Smad3 reveals and essential role in transforming growth factor beta-mediated signal transduction
146. STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling
147. Integrating multiple paracrine regulators of renal microvascular dynamics
148. Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients
149. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy
150. Cellular mechanisms involved in the vascular myogenic response
151. Vascular muscle cell depolarization and activation in renal arteries on elevation of transmural pressure
152. Cellular and ionic signal transduction mechanisms for the mechanical activation of renal arterial vascular smooth muscle
153. Pressurization of isolated renal arteries increases inositol triphosphate and diacylglycerol
154. 20-HETE and the kidney: Resolution of old problems and new beginnings
155. Pressure-mediated vasoconstriction of juxtamedullary afferent arterioles involves P2-purinoceptor activation
156. Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity
157. 2+ signaling in preglomerular smooth muscle cells
158. Dynamics of myosin light chain phosphorylation at Ser19 and Thr18/Ser19 in smooth muscle cells in culture
159. Signal transduction and regulation in smooth muscle
160. Effect of elevated extracellular glucose concentrations on transmembrane calcium ion fluxes in cultured rat VSMC
161. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus
162. High glucose inhibits cytosolic calcium signaling in cultured rat mesangial cells
163. Calcium signaling and contractile response of diabetic glomerular mesangial cells
164. High glucose alters actin assembly in glomerular mesangial and epithelial cells
165. Mesangial cell actin disassembly in high glucose mediated by protein kinase C and the polyol pathway
166. Cellular mechanisms in the development and progression of diabetic nephropathy: Activation of the DAG-PKC-ERK pathway
167. Regulation of actin organization by TGF-b in H-ras-transformed fibroblasts
168. TGF-beta type II receptor in rat renal vascular development: Localization to juxtaglomerular cells
169. Renal vascular induction of TGF-β2 and renin by potassium depletion
170. 2+ mobilization
171. 3Rs by TGF-β is associated with impaired calcium release in mesangial cells
172. Transforming growth factor beta 1 modulates angiotensin II-induced calcium influx in vascular smooth muscle
173. Transforming growth factor-b1 inhibits type I inositol 1,4,5-trisphosphate receptor expression and enhances its phosphorylation in mesangial cells
174. 2+ by cAMP in vascular smooth muscle cells
175. Transfected cGMP-dependent protein kinase suppresses calcium transients by inhibition of inositol 1,4,5-triphosphate production
176. Studies of the molecular mechanism of discrimination between cGMP and cAMP in the allosteric sites of the cGMP-binding cGMP-specific phosphodiesterase (PDE5)
177. Localization of inositol 1,4,5-trisphosphate receptors in the rat kidney
178. Renal type I inositol 1,4,5-trisphosphate receptor is reduced in streptozotocin-induced diabetic rats and mice
179. Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: Role of nitric oxide
180. Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats
181. Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS
182. Acute and chronic renal effects of recombinant human TGF-b2 in the rat
183. Renal fibrosis in mice treated with human recombinant transforming growth factor B2
184. Effect of anti-transforming growth factor B antibodies in cyclosporine-induced renal dysfunction